ArticleAvicenna journal of phytomedicine
Effects of sumac aqueous extract along with eating and drinking modification on functional dyspepsia symptoms in comparison with omeprazole: An open-label, randomized, controlled clinical trial.
Article in Avicenna journal of phytomedicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Functional dyspepsia (FD), a common gastrointestinal problem. The aim of the study was to evaluate the influence of Materials and Methods: This randomized controlled clinical trial study included 104 patients aged 18 to 60 years diagnosed with FD according to the ROME IV criteria. Four groups were formed: A) sumac extract + dietary changes, B) dietary changes, C) sumac extract and D) omeprazole. During the present eight-week study, patients' FD symptoms were assessed using the Gastrointestinal Symptom Rating Scale (GSRS) in four sessions. The Nepean Dyspepsia Index (NDI-10) was used to measure the impact of the interventions on patients' quality of life. Results: The study employed generalized estimating equation (GEE) analysis and found that symptom severity decreased across all groups during the intervention period. At the fourth week, no notable difference was noted between the omeprazole group and others. After the intervention, the severity of symptoms increased, especially in the omeprazole group, resulting in a significant difference compared to other groups. Conclusion: It seems that as a complementary treatment in FD, sumac might be effective with a more lasting effect with a significantly less recurrence of symptoms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.